TABLE 1.
Isolation of HIV-1 biological clones from three patients who did not develop X4 phenotype virusa
Patient | Date | No. of CD4+ cells/μl | CD4+/ CD8+ | Biological clone | TCID50/ml |
---|---|---|---|---|---|
ACH424b | 9/1/88 | 660 | 0.45 | 9F4 | 3.31 × 103 |
9H1 | 5.01 × 103 | ||||
5/21/92 | 110 | 0.17 | 23A1 | 1.66 × 104 | |
23G2 | 2.51 × 104 | ||||
ACH142c | 8/18/86 | 720 | 1.06 | 8A4 | 7.41 × 103 |
8G9 | 5.01 × 103 | ||||
8/25/92 | 310 | 0.09 | 32A7 | 3.72 × 104 | |
32D2 | 2.51 × 104 | ||||
4/28/94 | 300 | 0.1 | *E11 | 3.72 × 104 | |
AMS198d | 9/4/89 | 430 | 3.3 | 1C10 | 8.32 × 104 |
1A11 | 5.01 × 103 | ||||
7/1/91 | 250 | 1.2 | 3F4 | 1.66 × 104 | |
3C7 | 2.51 × 104 | ||||
9/16/93 | 30 | 0.27 | 4A2 | 1.12 × 104 |
R5 HIV-1 biological clones were isolated from three patients in the Amsterdam cohort at different stages of disease. At each time point, blood was drawn and the numbers of CD4+ and CD8+ T cells per microliter were determined. Biological clones were isolated by limiting dilution of PBMC at each time point, stocks were made, and the titer was measured on PBMC.
Seroconversion, 8/22/88; AIDS, 10/18/91 Candida esophagitis); deceased, 2/09/94.
Seroconversion, before 1986; AIDS, 1991; deceased, 9/16/93.
Seroconversion, before 11/22/84; AIDS, 12/15/93 (Kaposi's sarcoma); deceased, 4/28/94.